Database : MEDLINE
Search on : Lip and Diseases [Words]
References found : 5473 [refine]
Displaying: 1 .. 10   in format [Detailed]

page 1 of 548 go to page                         

  1 / 5473 MEDLINE  
              next record last record
select
to print
Photocopy
Full text

[PMID]: 23851893
[Au] Autor:Patil P; Chandan S; Singh V; Gadre K; Halli R; Gadre P
[Ad] Address:Department of Oral and Maxillofacial Surgery, School of Dental Sciences, Krishna Institute of Medical Sciences, Deemed University, Karad, Maharashta, India.
[Ti] Title:Numbness over the distribution of trigeminal nerve--trigeminal trophic syndrome or viral neuritis: a diagnostic dilemma!
[So] Source:J Craniofac Surg;24(4):e432-4, 2013 Jul.
[Is] ISSN:1536-3732
[Cp] Country of publication:United States
[La] Language:eng
[Ab] Abstract:Numbness and ulceration of the face, particularly erosion of ala of the nose, sometimes occur after sensory denervation in the territory of the divisions of the trigeminal nerve. The incidence is uncertain and usually follows surgical treatments for trigeminal neuralgia. Such condition is known as trigeminal trophic syndrome (TTS), although some authors believe it to be a special form of dermatitis artefacta. Trigeminal trophic syndrome most commonly affects adults, after iatrogenic, vascular, viral, or neoplastic damage to the trigeminal nerve. We present a rare case of TTS in a 32-year-old woman who was referred to us with progressive numbness in the right upper and lower lip region.
[Mh] MeSH terms primary: Hypesthesia/diagnosis
Trigeminal Nerve Diseases/diagnosis
[Mh] MeSH terms secundary: Adult
Diagnosis, Differential
Disease Progression
Female
Humans
Hypesthesia/drug therapy
Lost to Follow-Up
Magnetic Resonance Imaging
Prednisone/therapeutic use
Syndrome
Trigeminal Nerve Diseases/drug therapy
[Pt] Publication type:JOURNAL ARTICLE
[Nm] Name of substance:VB0R961HZT (Prednisone)
[Em] Entry month:1407
[Js] Journal subset:D
[Da] Date of entry for processing:130715
[St] Status:MEDLINE
[do] DOI:10.1097/SCS.0b013e3182942dff

  2 / 5473 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 23851889
[Au] Autor:Weathers WM; Wolfswinkel EM; Albright SB; Hollier LH; Buchanan EP
[Ad] Address:Division of Plastic Surgery, Baylor College of Medicine Houston, TX 77030-2399, USA. William.weathers@bcm.edu
[Ti] Title:Frontonasal and fibrous dysplasia in a patient with unilateral cleft lip and palate.
[So] Source:J Craniofac Surg;24(4):e422-4, 2013 Jul.
[Is] ISSN:1536-3732
[Cp] Country of publication:United States
[La] Language:eng
[Ab] Abstract:Frontonasal dysplasia is a rare entity. It has characteristic physical deformities: hypertelorism, broad nasal root, median facial cleft of the upper lip or palate, clefting of the nasal alae, poorly formed nasal tip, cranium bifidum occultum, and a widow's peak hairline. Fibrous dysplasia is a benign bone tumor in which normal bone is replaced by fibrous, poorly formed osseus tissues. We present a patient with frontonasal dysplasia who desired correction of her hypertelorism. Incidentally, fibrous dysplasia was found in her left orbit complicating surgical correction. In addition, the patient has velopharyngeal insufficiency and a class III malocclusion. The interplay of all these craniofacial defects makes the sequencing and timing of surgery important in this unique patient.
[Mh] MeSH terms primary: Abnormalities, Multiple
Cleft Lip/surgery
Cleft Palate/surgery
Craniofacial Abnormalities/diagnosis
Face/abnormalities
[Mh] MeSH terms secundary: Adolescent
Female
Fibrous Dysplasia of Bone/diagnosis
Humans
Hypertelorism/diagnosis
Malocclusion, Angle Class III/diagnosis
Orbital Diseases/diagnosis
Velopharyngeal Insufficiency/diagnosis
[Pt] Publication type:CASE REPORTS; JOURNAL ARTICLE
[Em] Entry month:1407
[Js] Journal subset:D
[Da] Date of entry for processing:130715
[St] Status:MEDLINE
[do] DOI:10.1097/SCS.0b013e3182942d27

  3 / 5473 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
PubMed Central Full text
Full text

[PMID]: 24341803
[Au] Autor:Soreze Y; Boutron A; Habarou F; Barnerias C; Nonnenmacher L; Delpech H; Mamoune A; Chrétien D; Hubert L; Bole-Feysot C; Nitschke P; Correia I; Sardet C; Boddaert N; Hamel Y; Delahodde A; Ottolenghi C; de Lonlay P
[Ti] Title:Mutations in human lipoyltransferase gene LIPT1 cause a Leigh disease with secondary deficiency for pyruvate and alpha-ketoglutarate dehydrogenase.
[So] Source:Orphanet J Rare Dis;8:192, 2013.
[Is] ISSN:1750-1172
[Cp] Country of publication:England
[La] Language:eng
[Ab] Abstract:BACKGROUND: Synthesis and apoenzyme attachment of lipoic acid have emerged as a new complex metabolic pathway. Mutations in several genes involved in the lipoic acid de novo pathway have recently been described (i.e., LIAS, NFU1, BOLA3, IBA57), but no mutation was found so far in genes involved in the specific process of attachment of lipoic acid to apoenzymes pyruvate dehydrogenase (PDHc), α-ketoglutarate dehydrogenase (α-KGDHc) and branched chain α-keto acid dehydrogenase (BCKDHc) complexes. METHODS: Exome capture was performed in a boy who developed Leigh disease following a gastroenteritis and had combined PDH and α-KGDH deficiency with a unique amino acid profile that partly ressembled E3 subunit (dihydrolipoamide dehydrogenase / DLD) deficiency. Functional studies on patient fibroblasts were performed. Lipoic acid administration was tested on the LIPT1 ortholog lip3 deletion strain yeast and on patient fibroblasts. RESULTS: Exome sequencing identified two heterozygous mutations (c.875C > G and c.535A > G) in the LIPT1 gene that encodes a mitochondrial lipoyltransferase which is thought to catalyze the attachment of lipoic acid on PDHc, α-KGDHc, and BCKDHc. Anti-lipoic acid antibodies revealed absent expression of PDH E2, BCKDH E2 and α-KGDH E2 subunits. Accordingly, the production of 14CO2 by patient fibroblasts after incubation with 14Cglucose, 14Cbutyrate or 14C3OHbutyrate was very low compared to controls. cDNA transfection experiments on patient fibroblasts rescued PDH and α-KGDH activities and normalized the levels of pyruvate and 3OHbutyrate in cell supernatants. The yeast lip3 deletion strain showed improved growth on ethanol medium after lipoic acid supplementation and incubation of the patient fibroblasts with lipoic acid decreased lactate level in cell supernatants. CONCLUSION: We report here a putative case of impaired free or H protein-derived lipoic acid attachment due to LIPT1 mutations as a cause of PDH and α-KGDH deficiencies. Our study calls for renewed efforts to understand the mechanisms of pathology of lipoic acid-related defects and their heterogeneous biochemical expression, in order to devise efficient diagnostic procedures and possible therapies.
[Mh] MeSH terms primary: Acyltransferases/genetics
Leigh Disease/genetics
[Mh] MeSH terms secundary: Amino Acids/blood
Amino Acids/cerebrospinal fluid
Amino Acids/urine
Carrier Proteins/genetics
Cells, Cultured
Fibroblasts/metabolism
Humans
Immunoblotting
Ketoglutarate Dehydrogenase Complex/deficiency
Ketoglutarate Dehydrogenase Complex/genetics
Ketone Oxidoreductases/deficiency
Ketone Oxidoreductases/genetics
Leigh Disease/blood
Leigh Disease/urine
Pyruvate Dehydrogenase (Lipoamide)/genetics
Thioctic Acid/blood
Thioctic Acid/cerebrospinal fluid
Thioctic Acid/urine
[Pt] Publication type:JOURNAL ARTICLE; RESEARCH SUPPORT, NON-U.S. GOV'T
[Nm] Name of substance:0 (Amino Acids); 0 (Carrier Proteins); 0 (NFU1 protein, human); 73Y7P0K73Y (Thioctic Acid); EC 1.2.- (Ketone Oxidoreductases); EC 1.2.1.51 (pyruvate dehydrogenase (NADP+)); EC 1.2.4.1 (Pyruvate Dehydrogenase (Lipoamide)); EC 1.2.4.1 (pyruvate dehydrogenase E1alpha subunit); EC 1.2.4.2 (Ketoglutarate Dehydrogenase Complex); EC 2.3.- (Acyltransferases); EC 2.3.1.- (lipoyltransferase I)
[Em] Entry month:1407
[Js] Journal subset:IM
[Da] Date of entry for processing:140130
[St] Status:MEDLINE
[do] DOI:10.1186/1750-1172-8-192

  4 / 5473 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 24134608
[Au] Autor:Jaipersad AS; Shantsila E; Blann A; Lip GY
[Ad] Address:University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, UK.
[Ti] Title:The effect of statin therapy withdrawal on monocyte subsets.
[So] Source:Eur J Clin Invest;43(12):1307-13, 2013 Dec.
[Is] ISSN:1365-2362
[Cp] Country of publication:England
[La] Language:eng
[Ab] Abstract:BACKGROUND: Three functionally distinct monocyte subsets have been identified. Statins are of undoubted effect in atherosclerosis and have numerous pleiotropic effects that contribute to their clinical success, but the effect of these drugs on monocyte subsets is unclear. We hypothesised a beneficial effect of statins on key receptor expression by monocyte subsets. MATERIAL AND METHODS: Effects of temporal (2 weeks) cessation of statin therapy by 66 patients with stable coronary artery disease on monocyte subsets [CD14++CD16-CCR2+ (Mon1), CD14++CD16+CCR2+ (Mon2) and CD14+CD16++CCR2- (Mon3)], their aggregates with platelets and their expression of a number of receptors involved in inflammation (IL-6 receptor), adhesion [vascular cell adhesion molecule (VCAM)], angiogenesis [vascular endothelial growth factor (VEGF)] and repair were assessed by flow cytometry. RESULTS: Statin cessation did not lead to any significant changes in absolute numbers of monocyte subsets or the degree of their aggregation with platelets. All monocyte subsets showed significant downregulation of expression of vascular endothelial factor receptor 2, Tie2 and Toll-like receptor-4 (TLR4; all changes P < 0·01). Expression of CXCR4 was only reduced in Mon1 cells (P = 0·013). There was no significant change in the expression of CD14, CD16, CCR4, IL6 receptor and VCAM (all P = NS). CONCLUSIONS: Statin withdrawal does not affect counts of any of monocyte subsets, but leads to downregulation of expression of TLR4 and receptors related to angiogenesis on all subsets, as well as a decrease in density of CXCR4 expression on 'classical' Mon1. These data provide further support of pleiotropic effects of statins and their effects on monocyte pro-angiogenic and proreparative characteristics.
[Mh] MeSH terms primary: Coronary Artery Disease/drug therapy
Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use
Monocytes/drug effects
[Mh] MeSH terms secundary: Aged
Angiopoietin-2/metabolism
Antigens, CD/drug effects
Antigens, CD/metabolism
Coronary Artery Disease/pathology
Enzyme-Linked Immunosorbent Assay
Female
Humans
Male
Receptors, Interleukin-6/metabolism
Vascular Cell Adhesion Molecule-1/metabolism
Vascular Endothelial Growth Factor A/metabolism
[Pt] Publication type:JOURNAL ARTICLE
[Nm] Name of substance:0 (Angiopoietin-2); 0 (Antigens, CD); 0 (Hydroxymethylglutaryl-CoA Reductase Inhibitors); 0 (Receptors, Interleukin-6); 0 (Vascular Cell Adhesion Molecule-1); 0 (Vascular Endothelial Growth Factor A)
[Em] Entry month:1407
[Js] Journal subset:IM
[Da] Date of entry for processing:131119
[St] Status:MEDLINE
[do] DOI:10.1111/eci.12183

  5 / 5473 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 24135446
[Au] Autor:Lip GY
[Ad] Address:University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, UK.
[Ti] Title:Using the CHADS2 and CHA2DS2-VASc scores for stroke risk prediction as well as the identification of stroke outcomes and cardiac complications in patients with and without atrial fibrillation.
[So] Source:Cerebrovasc Dis;36(4):281-2, 2013.
[Is] ISSN:1421-9786
[Cp] Country of publication:Switzerland
[La] Language:eng
[Mh] MeSH terms primary: Atrial Fibrillation/complications
Decision Support Techniques
Stroke/etiology
[Mh] MeSH terms secundary: Female
Humans
Male
[Pt] Publication type:COMMENT; JOURNAL ARTICLE
[Em] Entry month:1407
[Js] Journal subset:IM
[Da] Date of entry for processing:131119
[St] Status:MEDLINE
[do] DOI:10.1159/000355981

  6 / 5473 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Clinical Trials Registry
Full text

[PMID]: 23765437
[Au] Autor:Schlitt A; Rubboli A; Lip GY; Lahtela H; Valencia J; Karjalainen PP; Weber M; Laine M; Kirchhof P; Niemelä M; Vikman S; Buerke M; Airaksinen KE; AFCAS (Management of patients with Atrial Fibrillation undergoing Coronary Artery Stenting Study Group)
[Ad] Address:Medical Faculty, Martin Luther-University Halle-Wittenberg, Halle, Germany; Department of Cardiology, Paracelsus Harz-Clinic, Bad Suderode, Germany.
[Ti] Title:The management of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: in-hospital-data from the Atrial Fibrillation undergoing Coronary Artery Stenting study.
[So] Source:Catheter Cardiovasc Interv;82(7):E864-70, 2013 Dec 1.
[Is] ISSN:1522-726X
[Cp] Country of publication:United States
[La] Language:eng
[Ab] Abstract:Current recommendations on the management of patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention with stent (PCI-S) essentially derive from small, single-center, retrospective datasets. To obtain larger and better quality data, we carried out the prospective, multicenter Atrial Fibrillation undergoing Coronary Artery Stenting (AFCAS) study. Therefore, consecutive patients with history of or ongoing AF undergoing PCI-S were enrolled, and occurrence of adverse ischemic and bleeding events recorded during 12 months follow-up. In this article, we report the in-hospital observations. Out of the 963 patients, in the majority of cases (49.1%) AF was permanent. The associated risk of stroke, as defined by a CHADS2 -score ≥2, was in 70% of patients moderate to high. Upon enrollment in the registry, 69.3% of patients were on VKA therapy. Overall occurrence of in-hospital major adverse cardiac events was 4.5% (cardiovascular death 1.9%, urgent revascularization in 1.5%, and stroke/arterial thromboembolism in 0.6%). Bleeding complications occurred in 7.1% of patients, being severe in 2.5%. In a logistic regression analysis, no risk factor was independently associated with bleeding events, whereas Clopidogrel treatment decreased and female gender/treatment with gpIIb/IIIa-antagonists, respectively increased the risk for the combined ischemic endpoint. The majority of AF patients undergoing PCI-S are at high stroke risk, and therefore VKA treatment should not be withdrawn and combined anticoagulant and antiplatelet treatment is warranted. Current management appears largely in accordance with current recommendations, whereby accounting for the limited occurrence of in-hospital adverse ischemic and bleeding events.
[Mh] MeSH terms primary: Anticoagulants/therapeutic use
Atrial Fibrillation/drug therapy
Coronary Artery Disease/therapy
Percutaneous Coronary Intervention/instrumentation
Stents
[Mh] MeSH terms secundary: Aged
Aged, 80 and over
Anticoagulants/adverse effects
Atrial Fibrillation/complications
Atrial Fibrillation/diagnosis
Atrial Fibrillation/mortality
Chi-Square Distribution
Coronary Artery Disease/complications
Coronary Artery Disease/diagnosis
Coronary Artery Disease/mortality
Europe
Female
Guideline Adherence
Hemorrhage/chemically induced
Hospital Mortality
Humans
Logistic Models
Male
Middle Aged
Percutaneous Coronary Intervention/adverse effects
Percutaneous Coronary Intervention/mortality
Platelet Aggregation Inhibitors/therapeutic use
Practice Guidelines as Topic
Prospective Studies
Registries
Risk Factors
Sex Factors
Stroke/etiology
Stroke/prevention & control
Thromboembolism/etiology
Thromboembolism/prevention & control
Time Factors
Treatment Outcome
[Pt] Publication type:JOURNAL ARTICLE; MULTICENTER STUDY; OBSERVATIONAL STUDY; RESEARCH SUPPORT, NON-U.S. GOV'T
[Nm] Name of substance:0 (Anticoagulants); 0 (Platelet Aggregation Inhibitors)
[Em] Entry month:1407
[Js] Journal subset:IM
[Da] Date of entry for processing:131122
[Cl] Clinical Trial:ClinicalTrial
[St] Status:MEDLINE
[do] DOI:10.1002/ccd.25064

  7 / 5473 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 23734765
[Au] Autor:Errichetti E; Piccirillo A; Viola L; Ricciuti F; Ricciuti F
[Ti] Title:Areolar sebaceous hyperplasia associated with oral and genital Fordyce spots.
[So] Source:J Dermatol;40(8):670, 2013 Aug.
[Is] ISSN:1346-8138
[Cp] Country of publication:England
[La] Language:eng
[Mh] MeSH terms primary: Breast Diseases/pathology
Choristoma
Lip Diseases
Penile Diseases
Sebaceous Glands
[Mh] MeSH terms secundary: Adult
Humans
Hyperplasia
Male
Sebaceous Glands/pathology
[Pt] Publication type:CASE REPORTS; LETTER
[Em] Entry month:1407
[Js] Journal subset:IM
[Da] Date of entry for processing:130805
[St] Status:MEDLINE
[do] DOI:10.1111/1346-8138.12191

  8 / 5473 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 24841239
[Au] Autor:Garuti G; Nicolini A; Grecchi B; Lusuardi M; Winck JC; Bach JR
[Ad] Address:Respiratory Rehabilitation Unit, San Sebastiano Hospital, Correggio, Reggio Emilia, Italy. Electronic address: garutigi@ausl.re.it....
[Ti] Title:Open circuit mouthpiece ventilation: Concise clinical review.
[So] Source:Rev Port Pneumol;20(4):211-8, 2014 Jul-Aug.
[Is] ISSN:0873-2159
[Cp] Country of publication:Portugal
[La] Language:eng; por
[Ab] Abstract:In 2013 new "mouthpiece ventilation" modes are being introduced to commercially available portable ventilators. Despite this, there is little knowledge of how to use noninvasive intermittent positive pressure ventilation (NIV) as opposed to bi-level positive airway pressure (PAP) and both have almost exclusively been reported to have been used via nasal or oro-nasal interfaces rather than via a simple mouthpiece. Non-invasive ventilation is often reported as failing because of airway secretion encumbrance, because of hypercapnia due to inadequate bi-level PAP settings, or poor interface tolerance. The latter can be caused by factors such as excessive pressure on the face from poor fit, excessive oral air leak, anxiety, claustrophobia, and patient-ventilator dys-synchrony. Thus, the interface plays a crucial role in tolerance and effectiveness. Interfaces that cover the nose and/or nose and mouth (oro-nasal) are the most commonly used but are more likely to cause skin breakdown and claustrophobia. Most associated drawbacks can be avoided by using mouthpiece NIV. Open-circuit mouthpiece NIV is being used by large populations in some centers for daytime ventilatory support and complements nocturnal NIV via "mask" interfaces for nocturnal ventilatory support. Mouthpiece NIV is also being used for sleep with the mouthpiece fixed in place by a lip-covering flange. Small 15 and 22mm angled mouthpieces and straw-type mouthpieces are the most commonly used. NIV via mouthpiece is being used as an effective alternative to ventilatory support via tracheostomy tube (TMV) and is associated with a reduced risk of pneumonias and other respiratory complications. Its use facilitates "air-stacking" to improve cough, speech, and pulmonary compliance, all of which better maintain quality of life for patients with neuromuscular diseases (NMDs) than the invasive alternatives. Considering these benefits and the new availability of mouthpiece ventilator modes, wider knowledge of this technique is now warranted. This review highlights the indications, techniques, advantages and disadvantages of mouthpiece NIV.
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1407
[Js] Journal subset:IM
[St] Status:In-Data-Review

  9 / 5473 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 23843086
[Au] Autor:Davoudi B; Morrison M; Bizheva K; Yang VX; Dinniwell R; Levin W; Vitkin IA
[Ad] Address:University of Toronto, Department of Medical Biophysics, Toronto, Ontario M5G 2M9, Canada. bahar.davoudi@utoronto.ca
[Ti] Title:Optical coherence tomography platform for microvascular imaging and quantification: initial experience in late oral radiation toxicity patients.
[So] Source:J Biomed Opt;18(7):76008, 2013 Jul.
[Is] ISSN:1560-2281
[Cp] Country of publication:United States
[La] Language:eng
[Ab] Abstract:An optical coherence tomography (OCT) microvascular imaging platform, consisting of Doppler (DOCT) and speckle variance (svOCT) modalities, and microvascular image quantification tools are developed. The quantification methods extract blood flow-related parameters from DOCT images and vessel morphological parameters from svOCT images. This platform is used to assess the microvascular (DOCT and svOCT) images obtained during a clinical study on late oral radiation toxicity. This specific pathology was considered a suitable scenario for verifying the performance of the developed quantification platform because late oral radiation toxicity is known to involve microvascular damage. The derived parameters are compared between several DOCT and svOCT images from one patient and one healthy volunteer as proof-of-principle, and the significance of the observed differences is discussed. Given the low number of OCT clinical studies that measure and quantify microvascular images and considering the importance of such quantification in a number of pathologies, this newly developed platform can serve as a useful tool in studying diseases and treatments with microvascular involvement.
[Mh] MeSH terms primary: Head and Neck Neoplasms/blood supply
Head and Neck Neoplasms/radiotherapy
Microcirculation/physiology
Radiation Injuries/pathology
Tomography, Optical Coherence/methods
[Mh] MeSH terms secundary: Case-Control Studies
Humans
Lip/blood supply
Radiation Injuries/etiology
Radiotherapy/adverse effects
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1402
[Cu] Class update date: 140707
[Lr] Last revision date:140707
[Js] Journal subset:IM
[Da] Date of entry for processing:130711
[St] Status:MEDLINE
[do] DOI:10.1117/1.JBO.18.7.076008

  10 / 5473 MEDLINE  
              first record previous record
select
to print
Photocopy
Full text

[PMID]: 23054221
[Au] Autor:Vaduganathan M; Greene SJ; Butler J; Sabbah HN; Shantsila E; Lip GY; Gheorghiade M
[Ad] Address:Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
[Ti] Title:The immunological axis in heart failure: importance of the leukocyte differential.
[So] Source:Heart Fail Rev;18(6):835-45, 2013 Nov.
[Is] ISSN:1573-7322
[Cp] Country of publication:United States
[La] Language:eng
[Ab] Abstract:The important role of the immune system and inflammation in the pathophysiology of heart failure (HF) is becoming increasingly appreciated. We have reviewed the prognostic significance of under-recognized aspects of the leukocyte differential in HF, including lymphocytes, monocytes, eosinophils and mast cells. Studies to date evaluating lymphocyte counts in both chronic and hospitalized HF patients have consistently shown worse prognosis associated with low lymphocyte counts, despite widely heterogeneous study designs. Limited data suggest elevations in monocyte-derived cytokines and serum monocyte count may be predictive of poor outcomes in HF. Further data are required to better define the relationship between eosinophils, mast cells and HF. Leukocyte differentials are widely available, simple, inexpensive and appear to have independent prognostic significance, beyond traditional risk factors. Enhanced sympathetic activation and increased circulating cytokine levels (particularly tumor necrosis factor) have been implicated in the variability of leukocyte subpopulations. To date, immune-modulators targeting these mediators have been largely unsuccessful in improving cardiovascular outcomes in HF. Given the potential role of the immunological axis in HF, there may be an unmet need for novel therapeutic agents that can safely and effectively ameliorate these leukocyte derangements and perhaps improve the unacceptably high event rate in this population. Variations in leukocyte differentials may identify a high-risk subset of patients that may benefit from tailored immune therapies.
[Mh] MeSH terms primary: Cell Differentiation/immunology
Heart Failure/immunology
Heart Failure/mortality
Leukocytes/cytology
[Mh] MeSH terms secundary: Acute Disease
Chronic Disease
Disease Progression
Eosinophils/cytology
Eosinophils/immunology
Female
Heart Failure/blood
Heart Failure/physiopathology
Humans
Leukocyte Count
Lymphocyte Count
Male
Mast Cells/cytology
Mast Cells/immunology
Monocytes/cytology
Monocytes/immunology
Sensitivity and Specificity
Severity of Illness Index
Survival Analysis
[Pt] Publication type:JOURNAL ARTICLE; REVIEW
[Em] Entry month:1407
[Js] Journal subset:IM
[Da] Date of entry for processing:131111
[St] Status:MEDLINE
[do] DOI:10.1007/s10741-012-9352-9


page 1 of 548 go to page                         
   


Refine the search
  Database : MEDLINE Advanced form   

    Search in field  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/PAHO/WHO - Latin American and Caribbean Center on Health Sciences Information